Physician profile
Emily Grade
NPI 1437124922
$733.90
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $78.65 · 2021: $111 · 2022: $67.23.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $217.45 | 2019-2021 | |
| Sirtex Medical INC | $188.93 | 2019 | |
| Siemens Medical Solutions USA, INC. | $150.29 | 2021-2022 | |
| Varian Medical Systems, INC. | $67.00 | 2020 | |
| Accuray Incorporated | $24.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.52 | 2019 | |
| Boston Scientific Corporation | $23.49 | 2019 | |
| Emd Serono, INC. | $14.65 | 2021 | |
| Genzyme Corporation | $12.50 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.65 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Grade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.